Evidence map›Paper›PMID 40551849›Full record

ArticleAdvances in virology2025

A Prospective Study of Immune Response After COVID-19 or Vaccination and Correlation Between Avidity Index and Neutralizing Capacity.

Emma Löfström, Anna Eringfält, Arne Kötz, Wanda Christ, Stefan Kunkel, Johan Tham, Jonas Klingström, Johan Undén

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advances in virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Emma LöfströmDepartment of Clinical Sciences, Lund University, Office DCSL, Lund 221 84, Sweden.ORCID https://orcid.org/0000-0003-4949-9060
Anna EringfältDepartment of Clinical Microbiology, Hallands Hospital Halmstad, Halmstad 301 85, Sweden.ORCID https://orcid.org/0009-0003-6362-5200
Arne KötzDepartment of Clinical Microbiology, Hallands Hospital Halmstad, Halmstad 301 85, Sweden.ORCID https://orcid.org/0000-0003-4344-9433
Wanda ChristDepartment of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm 14186, Sweden.ORCID https://orcid.org/0000-0003-3886-5248
Stefan KunkelDepartment of Research and Development, Hallands Hospital Halmstad, Halmstad 301 85, Sweden.ORCID https://orcid.org/0009-0004-1211-1936
Johan ThamDepartment of Translational Medicine, Clinical Infection Medicine, Skåne University Hospital, Lund University, Malmö 205 02, Sweden.ORCID https://orcid.org/0000-0002-6994-1672
Jonas KlingströmDepartment of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm 14186, Sweden.ORCID https://orcid.org/0000-0001-9076-1441
Johan UndénDepartment of Operation and Intensive Care, Hallands Hospital Halmstad, Halmstad 301 85, Sweden.ORCID https://orcid.org/0000-0002-8344-5720

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

anti-spike IgGavidityCOVID-19immune responseneutralizing titerSARS-CoV-2

Identifiers

PMID40551849
PMCPMC12185213

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.